If you've been living with PCOS for any length of time, you've probably fallen down at least one supplement rabbit hole at 11pm, wondering which ones are actually worth your time.

Chromium tends to show up on those lists, often with big claims and not a lot of explanation. So let's change that.

This is what I wish someone had explained to me clearly, without the hype or the oversimplification: what chromium actually is, what the research genuinely shows, and whether it might be worth considering as part of your PCOS strategy.

Chromium is a trace mineral — meaning your body needs it in tiny amounts, but those amounts still matter. It exists in two primary forms: trivalent chromium, which is the form found in food and supplements and is safe for human consumption, and hexavalent chromium, which is an industrial toxin you'll recognise from Erin Brockovich. We're only talking about trivalent chromium here.

The reason chromium keeps appearing in PCOS conversations comes down to one key mechanism: its relationship with insulin.

Insulin resistance is present in an estimated 70–80% of women with PCOS, including those who are a healthy weight [Anderson, 1998]. When your cells stop responding effectively to insulin, your pancreas produces more of it to compensate. That surge of insulin drives up androgen production in the ovaries, which is one of the central drivers of PCOS symptoms — irregular cycles, acne, hair changes, and weight gain that doesn't respond to the usual approaches.

Chromium appears to support the action of insulin at a cellular level. It works by interacting with a molecule called chromodulin (sometimes called LMWCr), which amplifies insulin signalling inside the cell. In simple terms: when chromium is present in adequate amounts, insulin doesn't have to work as hard to get glucose into your cells [Havel PJ, 2004].

That's the mechanism that makes chromium relevant for PCOS — not as a miracle fix, but as a nutrient that may help the underlying insulin signalling dysfunction that drives so many of the symptoms.

Chromium picolinate supplementation has been shown in some studies to modestly improve insulin sensitivity in women with PCOS, particularly those with insulin resistance — though study sizes remain small.

A study published in Fertility and Sterility found that chromium picolinate supplementation improved insulin sensitivity in obese subjects with polycystic ovary syndrome [Lydic et al., 2006]. This is directly relevant, because improving insulin sensitivity is one of the foundational goals of managing PCOS metabolically — it affects cycle regularity, androgen levels, and long-term health.

A scientific review examining chromium's role in insulin resistance broadly concluded that chromium supplementation had measurable effects on insulin action, particularly in contexts where insulin resistance was already present [Havel PJ, 2004].

A separate study gave 40 women with PCOS 200 mcg of chromium picolinate or a placebo for eight weeks. The chromium group showed reductions in fasting blood sugar, insulin, triglycerides, and total cholesterol compared to the placebo group [Geohas et al., 2007]. That's a meaningful combination of markers — not just one number improving, but a broader metabolic shift.

It's worth being honest here: many of these studies are small, and the research overall isn't yet large enough to make definitive statements. But the direction of the evidence is consistent, and that matters when you're thinking about what to support your body with.

Some research suggests chromium supplementation may improve BMI and free testosterone in PCOS patients, though its effects on total testosterone and other androgens appear more limited.

A systematic review published in the Journal of Pediatric and Adolescent Gynecology found that chromium supplementation had a beneficial effect on BMI and free testosterone concentration in women with PCOS [Amr and Abdel-Rahim, 2015]. Free testosterone is particularly relevant here — it's the active, unbound form that drives symptoms like acne and excess hair growth.

The same review noted that chromium did not significantly affect total testosterone, DHEA, FSH, or LH. This is a nuance worth understanding: chromium isn't addressing every hormonal marker, but it may be contributing to improvements in the ones most directly connected to insulin-androgen signalling.

Chromium supplementation has been associated with improvements in glucose homeostasis and lipid profiles, particularly in the presence of insulin resistance or type 2 diabetes.

A double-blind, randomised clinical trial found that chromium supplementation had a positive effect on glucose homeostasis in type 2 diabetic patients [Alkhalidi, 2023]. While PCOS and type 2 diabetes are different conditions, they share the insulin resistance pathway — which is why the overlap in research is informative.

A systematic review and meta-analysis of randomised controlled trials found that chromium supplementation had a positive effect on lipid profiles in patients with type 2 diabetes, including improvements in total cholesterol and triglycerides [Tarrahi et al., 2021]. Elevated triglycerides and cholesterol are more common in women with PCOS than in the general population, making this relevant beyond blood sugar alone.

The evidence for chromium as a standalone weight loss tool is modest — studies show small but consistent reductions in body weight, with more meaningful effects seen on insulin and metabolic markers.

This is where it's important to be realistic rather than hopeful.

A large Cochrane review analysed nine studies involving 622 overweight or obese adults given up to 1,000 mcg/day of chromium picolinate. The average weight loss was around 1.1 kg (2.4 pounds) over 12 to 16 weeks — statistically measurable but not dramatic [Tian et al., 2013].

Another analysis of eleven studies found similar results: approximately 0.5 kg of weight loss with 8 to 26 weeks of supplementation.

Here's the more useful framing: for women with PCOS, the struggle with weight isn't simply a calorie problem. It's driven by insulin resistance, hormonal signalling, and metabolic dysregulation. Chromium isn't going to replace the foundational work — blood sugar stability, strength training, adequate protein, sleep — but it may support the environment in which that work becomes more effective.

One study specifically examined chromium's impact on metabolic markers including leptin, adiponectin, and oxidative stress, giving participants 400 mcg daily for 12 weeks and finding significant changes in those metabolic markers alongside changes in body weight [Kooshki et al., 2021]. Leptin and adiponectin are both involved in hunger signalling and fat metabolism — disrupted in PCOS — which is a more nuanced story than "chromium = weight loss."

Not all chromium supplements are created equal. The form matters for absorption and effectiveness.

Chromium picolinate is the form most extensively studied in PCOS and insulin resistance research. It's formed by combining chromium with picolinic acid, which improves absorption across the gut wall. This is the form used in the majority of clinical trials cited in this article and the form included in MyOva's Myoplus supplement.

Other forms you'll see include chromium chloride (less bioavailable), chromium polynicotinate, and chromium histidinate. Picolinate remains the most researched form for the specific outcomes relevant to PCOS.

Before reaching for supplements, it's worth knowing what chromium looks like in a food-first approach.

Chromium is naturally present in a range of everyday foods, though the amounts are small — measured in micrograms:

• Whole grains — wholemeal bread, oats, and wholegrains generally are among the better sources
• Meat — particularly beef and ham
• Eggs — approximately 0.2 mcg per egg
• Fruit — particularly grape juice (around 7.5 mcg per cup) and oranges
• Brewer's yeast — historically a concentrated source, though less commonly consumed today
• Vegetables — varying amounts depending on the type

The NHS suggests that around 25 micrograms of chromium per day should be sufficient for most adults. However, the typical Western diet often falls short of even this modest threshold, and women with PCOS may have higher requirements due to increased chromium excretion — one mechanism that has been proposed to explain the lower chromium levels sometimes observed in PCOS [Anderson, 1998].

Getting therapeutic amounts through food alone is challenging, which is why supplementation enters the conversation.

The NHS guidance of around 25 mcg per day represents a baseline for general health. Clinical trials in PCOS and insulin resistance contexts have used significantly higher doses — typically in the range of 200 to 1,000 mcg per day, most commonly 200 to 400 mcg.

Pharmacologic doses used in research settings (200–500 mcg) are generally considered safe for most people. Chromium does not have an established tolerable upper intake level (UL) in the same way that some other nutrients do.

That said, dose isn't something to self-prescribe in isolation. The right amount depends on your overall supplement and medication picture, which is why a conversation with your GP or a registered nutritionist before starting is always the sensible step.

Chromium is considered safe for most healthy adults at the doses used in clinical research. But there are specific interactions worth being aware of:

Insulin and diabetes medications — Chromium can enhance insulin sensitivity, which means if you're already on medication that lowers blood sugar, there's a theoretical risk of hypoglycaemia. If this applies to you, blood sugar monitoring and a conversation with your prescriber is essential before adding chromium.

NSAIDs and aspirin — These can increase chromium absorption in the body. If you regularly use ibuprofen or aspirin, bear this in mind.

Levothyroxine (thyroid medication) — Chromium can reduce the absorption of levothyroxine. The guidance is to take levothyroxine at least 30 minutes before, or 3–4 hours after, taking chromium.

Liver or kidney disease — Higher doses of chromium have been associated with liver and kidney strain in some case reports. Anyone with existing liver or kidney conditions should approach supplementation cautiously and under medical supervision.

Psychiatric medications — Chromium may affect brain chemistry; if you're taking medication for depression, anxiety, or similar conditions, discuss chromium supplementation with your prescriber first.

If you're exploring chromium as part of your PCOS support, it makes sense to look at it within the context of your whole supplement approach rather than in isolation.

MyOva's Myoplus supplement combines chromium picolinate with myo-inositol, folate (as L-5-methyltetrahydrofolate), and vitamin B6 — each ingredient chosen for a specific role in hormonal and metabolic health.

Myo-inositol is one of the most extensively researched supplements for PCOS. It works at the intracellular signalling level to improve insulin sensitivity, support ovulation, and help regulate androgen production — making it a natural companion to chromium's insulin-supporting role. Together, they're addressing insulin resistance through complementary mechanisms rather than a single pathway.

Folate in its methylated form (L-5-MTHF) is essential for anyone with PCOS who is thinking about pregnancy, and vitamin B6 plays a role in progesterone metabolism and reducing PMS symptoms.

It's not a magic fix. But it gives your body what it's often missing — a combination of nutrients that work with your biology, not around it.

For most women with PCOS, chromium picolinate at doses used in research (200–400 mcg per day) appears safe. It becomes more complex if you're on blood sugar medication, thyroid medication, or have liver or kidney conditions — in those cases, speak with your GP before starting. It's not a standalone treatment, but it can be a supportive addition to a broader PCOS strategy.

Most studies showing measurable changes in insulin and metabolic markers ran for eight weeks to six months. Expect at least eight weeks of consistent use before evaluating whether it's making a difference, and assess changes in energy, blood sugar stability, and PMS severity rather than looking for dramatic weight changes.

Chromium is present in whole grains, meat, eggs, and some fruits, but in very small amounts. Getting the doses used in clinical research purely through diet is challenging for most people. A supplement can help close that gap, particularly if you're not consuming a varied, whole-food-rich diet consistently.

Research suggests chromium may help reduce free testosterone in PCOS patients and has a positive effect on BMI, but it doesn't appear to significantly impact total testosterone, LH, or FSH. Its primary route of impact on hormones is likely via insulin — by improving insulin sensitivity, it can help reduce the insulin-driven androgen production at the ovaries.

There's a logical case for combining them. Chromium and myo-inositol both support insulin signalling, but via different mechanisms. Several clinical studies and formulations have combined them, and MyOva's Myoplus is designed with this pairing in mind. If you're considering both, a combined supplement reduces the guesswork around doses and compatibility.

Chromium isn't a silver bullet for PCOS. The research is honest about this — study sizes are often small, and the effects are modest rather than dramatic.

But here's what is true: chromium picolinate has a biologically plausible mechanism that is directly relevant to PCOS, improvements in insulin sensitivity, blood sugar regulation, and some metabolic markers have been consistently observed across multiple independent studies, and it appears safe for most women at the doses used in research.

The research on this is actually pretty clear in its direction, even if the magnitude of effect is modest. For a condition like PCOS where insulin resistance sits at the root of so many symptoms, supporting insulin signalling from multiple angles makes metabolic sense.

If you're building a PCOS strategy that prioritises root cause over symptom suppression, chromium is worth understanding — not as an answer on its own, but as one well-evidenced piece of the picture.

As always, bring your GP or a registered nutritionist into this conversation before starting anything new, particularly if you're on medication.

• What Is PCOS? Your Complete Guide to Polycystic Ovary Syndrome
• Myo-Inositol and PCOS: What the Research Actually Shows
• Insulin Resistance and PCOS: Why It's the Root Cause Most Doctors Don't Explain
• PCOS and Blood Sugar: How to Eat to Support Your Hormones
• The MyOva Supplement Guide: What to Take, When, and Why

1. Lydic ML, McNurlan M, Bembo S, Mitchell L, Komaroff E, Gelato M. Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome. Fertil Steril. 2006 Jul;86(1):243-6. doi: 10.1016/j.fertnstert.2005.11.069. PMID: 16730719.

2. Alkhalidi F. A comparative study to assess the use of chromium in type 2 diabetes mellitus. J Med Life. 2023 Aug;16(8):1178-1182. doi: 10.25122/jml-2023-0081. PMID: 38024820; PMCID: PMC10652672.

3. Tarrahi MJ, Tarrahi MA, Rafiee M, Mansourian M. The effects of chromium supplementation on lipid profile in humans: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research. 2021;164:105308. doi: 10.1016/j.phrs.2020.105308.

4. Martin J, Wang ZQ, Zhang XH, Wachtel D, Volaufova J, Matthews DE, Cefalu WT. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care. 2006 Aug;29(8):1826-32. doi: 10.2337/dc06-0254. PMID: 16873787.

5. Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14. PMID: 15208835.

6. Tian H, Guo X, Wang X, He Z, Sun R, Ge S, Zhang Z. Chromium picolinate supplementation for overweight or obese adults. Cochrane Database Syst Rev. 2013 Nov 29;2013(11):CD010063. doi: 10.1002/14651858.CD010063.pub2. PMID: 24293292; PMCID: PMC7433292.

7. Amr N, Abdel-Rahim HE. The Effect of Chromium Supplementation on Polycystic Ovary Syndrome in Adolescents. Journal of Pediatric and Adolescent Gynecology. 2015;28(2):114-118. doi: 10.1016/j.jpag.2014.05.005.

8. Geohas J, Daly A, Juturu V, et al. Chromium Picolinate and Biotin Combination Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes Mellitus: A Placebo-Controlled, Double-Blinded, Randomized Clinical Trial. The American Journal of the Medical Sciences. 2007;333(3):145-153.

9. Kooshki F, Moradi F, Karimi A, Niazkar HR, Khoshbaten M, Maleki V, Pourghassem Gargari B. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2021 Oct 1;33(10):1298-1306. doi: 10.1097/MEG.0000000000001830. PMID: 32804855.

The information in this article is for educational purposes only and does not constitute medical advice. Always consult your GP or a qualified healthcare professional before starting any new supplement, particularly if you are pregnant, breastfeeding, or taking prescription medication.